| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |